Augmentin powder for suspension 400mg + 57mg \ 5ml bottle 70ml
-
All payments are encrypted via SSL
-
Full Refund if you haven't received your order
Active ingredient and dosage form
Coated Tablets from white to almost white, oval, with “AUGMENTIN” inscribed on one side; on a kink - from almost white to yellowish-white.
1 pill contains Amoxicillin (in the form of trihydrate) - 250 mg, clavulanic acid (in the form of potassium salt) - 125 mg;
auxiliary substances: Magnesium stearate, sodium starch glycolate type A, anhydrous colloidal silicon, microcrystalline cellulose;
Shell composition: titanium dioxide, hydroxypropylmethylcellulose (5 cps), hydroxypropylmethylcellulose (15 cps), polyethylene glycol 4000, polyethylene glycol 6000, dimethicone (silicone oil).
10 pieces. in aluminum foil blister, 2 blisters in a carton box.
Coated tablets: 1 pill contains amoxicillin (in the form of trihydrate) - 500 mg, clavulanic acid (in the form of potassium salt) - 125 mg;
7 or 10 pieces in aluminum foil blister, 2 blisters in a carton box.
Coated Tablets white to almost white, oval, with the letters "A" and "C" on both sides of the pill and the fault line on one side; on a kink - from almost white to yellowish-white.
1 pill contains amoxicillin (in the form of trihydrate) - 875 mg, clavulanic acid (in the form of potassium salt) - 125 mg;
7 piecesin aluminum foil blister, 2 blisters in a carton box.
Powder for suspension for oral administration white or almost white in color, with a characteristic odor; prepared suspension of white or almost white color.
5 ml of the prepared suspension contains amoxicillin (in the form of trihydrate) - 125 mg, clavulanic acid (in the form of potassium salt) - 31.25 mg;
Excipients: Xanthan gum, aspartame, succinic acid, colloidal silicon, hydroxypropylmethylcellulose, silicon dioxide, dry orange flavoring 610271E (Tastemaker) and 9/027108 (Dragoco), dry raspberry flavoring NN07943 (Quest), dry flavoring "Light-ness; );
11.5 g of powder in a 100 ml vial, 1 vial complete with a measuring cap in a cardboard box.
Powder for suspension for oral administration: 5 ml of the prepared suspension contains amoxicillin (in the form of trihydrate) - 200 mg, clavulanic acid (in the form of potassium salt) - 28.5 mg;
7.7 g of powder in a 70 ml vial, 1 vial complete with a measuring cap in a cardboard box.
Powder for suspension for oral administration: 5 ml of the prepared suspension contains amoxicillin (in the form of trihydrate) - 400 mg, clavulanic acid (in the form of potassium salt) - 57 mg;
12.6 g of powder in a bottle of 70 ml, 1 bottle complete with a measuring cap in a cardboard box.
Powder for solution for intravenous administration from white to almost white.
1 bottle contains amoxicillin (in the form of trihydrate) - 500 or 1000 mg, clavulanic acid (in the form of potassium salt) - 100 or 200 mg, respectively;
10 bottles in a carton box.
- tab.shell, 500 mg + 125 mg: - P №011997 / 01-2000 06.06.05PR
- tab. shell, 250 mg + 125 mg; 875 mg + 125 mg: - P No. 0105030 / 02-2003 30.06.03
- powder d / prigot. suspen d / ingestion 125 mg + 31.25 mg / 5 ml: - P No. 0105030 / 01-2003 03.06.03
- powder d / prigot. suspen d / ingestion 200 mg + 28.5 mg / 5 ml; 400 mg + 57 mg / 5 ml: - P No. 0155030 / 04.09.09.03
- powder d / prigot. p-ra d / in / in the introduction of 500 mg + 100 mg, 1 g + 200 mg: - P №015030 / 03-2003 30.06.03
Mechanism of action
Combined broad-spectrum antibiotic, resistant to the action of b-lactamase, containing amoxicillin and clavulanic acid.
Amoxicillin is a semi-synthetic broad-spectrum antibiotic that is active against many gram-positive and gram-negative microorganisms. Amoxicillin is destroyed by b-lactamases, therefore microorganisms producing b-lactamase are not included in the spectrum of its antibacterial activity.
Clavulanic acid, a b-lactam compound, has the ability to inactivate a wide range of b-lactamases, enzymes that usually produce microorganisms that are resistant to penicillins and cephalosporins.
The presence of clavulanic acid in Augmentin composition protects amoxicillin from the destructive action of b-lactamase and expands the spectrum of its antibacterial activity with the inclusion of microorganisms, usually resistant to other penicillins and cephalosporins.
Augmentin effective against gram-positive aerobic microorganisms: Bacillis anthracis*, Corynebacterium spp., Enterococcus faecalis*, Enterococcus faecium*, Listeria monocytogenes, Nocardia asteroides, Staphylococcus aureus*, coagulase-negative staphylococci (including Staphylococcus epidermidis), Streptococcus spp.(including Streptococcus agalactiae, Streptococcus pneumoniae, Streptococcus pyogenes, Streptococcus viridans); for gram-positive anaerobic microorganisms: Clostridium spp., Peptococcus spp., Peptostreptococcus spp.; for gram-negative aerobic microorganisms: Bordetella pertussis, Brucella spp., Escherichia coli*, Gardnerella vaginalis, Haemophilus influenzae*, Helicobacter pylori, Klebsiella spp.*, Legionella spp., Moraxella catarrhalis* (Branhamella catarrhalis), Neisseria gonorrhoeae*, Neisseria meningitidis*, Pasteurella multocida, Proteus mirabilis*Proteus vulgaris*, Salmonella spp.*, Shigella spp.*, Vibrio cholerae, Yersinia enterocolitica*; for gram-negative anaerobic microorganisms: Bacteroides spp*. (including Bacteroides fragilis), Fusobacterium spp.*; for other microorganisms: Borrelia burgdorferi, Chlamydiae, Leptospira icterohaemorrhagiae, Treponema pallidum.
* Some strains of these types of bacteria produce b-lactamase, which causes resistance to amoxicillin monotherapy.
Indications and usage
Infectious and inflammatory diseases caused by microorganisms sensitive to the drug:
- infections of the upper respiratory tract and upper respiratory tract (including recurrent tonsillitis, sinusitis, otitis media), usually caused by Streptococcus pneumoniae, Haemophilus influenzae and Moraxella catarrhalis and Streptococcus pyogenes;
- lower respiratory tract infections: exacerbations of chronic bronchitis, lobar pneumonia and bronchopneumonia, usually caused by Streptococcus pneumoniae, Haemophilus influenzae and Moraxella catarrhalis;
- infections of the urinary tract: cystitis, urethritis, pyelonephritis, infections of the female genital organs, usually caused by species of the family Enterobacteriaceae (mainly Escherichia coli), Staphylococcus saprophyticus and species of the genus Enterococcus, as well as gonorrhea caused by Neisseria gonorrhoeae;
- infections of the skin and soft tissues, usually caused by Staphylococcus aureus, Streptococcus pyogenes and species of the genus Bacteroides;
- infections of bones and joints: osteomyelitis, usually caused by Staphylococcus aureus, with the need for long-term therapy;
- other mixed infections, such as septic abortion, obstetric sepsis, intra-abdominal infections.
Contraindications
- jaundice or abnormal liver function in the history of Augmentin's use;
- hypersensitivity to beta-lactam antibiotics (including penicillins and cephalosporins).
Carefully should be used for infectious mononucleosis, pregnancy, lactation, gastrointestinal diseases (including if there is a history of indications of transferred colitis associated with the use of penicillins), chronic renal failure.
The dosage regimen is set individually depending on the age, body weight, renal function of the patient, as well as the severity of the infection.
For optimal absorption and reduction of possible side effects from the digestive system, Augmentin is recommended to be taken at the beginning of a meal.
Treatment should not be continued for more than 14 days without revising the clinical situation.
If necessary, it is possible to conduct stepwise therapy (at the beginning of the intravenous injection of the drug with the subsequent transition to oral administration).
Adults and children over 12 years old or with a body weight of more than 40 kg
1 pill (875 mg + 125 mg) 2 times / day or 1 pill (500 mg + 125 mg) 3 times / day.
Children under 12 years old
The dose, depending on age and body weight, is indicated in mg / kg of body weight per day, or in ml of suspension.
The recommended dosing regimen: 45 mg / kg / day in 2 doses or 40 mg / kg / day in 3 doses. The multiplicity of reception depends on the form of release.
Children weighing 40 kg or more the drug should be prescribed in the same doses as adults.
Single doses of the drug Augmentin, depending on age and body weight are presented in the table.
Age | Body mass | 2 times / day | 3 times / day |
---|---|---|---|
Up to 1 year | 2-5 kg | Suspension 200 mg * / 5 ml 1.5 - 2.5 ml | Suspension 125 mg * / 5 ml 1.5 - 2.5 ml |
6-9 kg | Suspension 200 mg * / 5 ml 5 ml | Suspension 125 mg * / 5 ml 5 ml | |
1-5 years | 10-18 kg | Suspension 400 mg * / 5 ml 5 ml | Suspension 125 mg * / 5 ml 10 ml |
6-9 years | 19-28 kg | Suspension 400 mg * / 5 ml - 7.5 ml or 1 pill 500 mg + 125 mg | Suspension 125 mg * / 5 ml - 15 ml or 1 pill 250 mg + 125 mg |
10-12 years | 29-39 kg | Suspension 400 mg * / 5 ml - 10 ml or 1 pill 500 mg + 125 mg | Suspension 125 mg * / 5 ml - 20 ml or 1 pill 250 mg + 125 mg |
Adults and children over 12 years old | More than 40 kg | 1 pill 875 mg + 125 mg | 1 pill 500 mg + 125 mg |
* Amoxicillin
Two tablets of Augmentin (250 mg + 125 mg) are not equivalent to one pill (500 mg + 125 mg), since the content of clavulanic acid in them is 2 times higher.
For the correct dosing volume of suspension at children under 3 months It is recommended to use a syringe with a graduation.
For the convenience of receiving children under 2 years the suspension can be diluted twice with water.
At treatment of infections of the skin and soft tissues, as well as recurrent tonsillitis the drug can be administered at a dose of 20 mg / kg / day in 3 doses (suspension 4: 1) and 25 mg / kg / day in 2 doses (suspension 7: 1).
If the frequency of excretion of pneumococcus with a high level of penicillin resistance (with penicillin BMD 2-4 mg / l) in the region (or closed institution) exceeds 10%, amoxicillin / clavulanate (Augmentin) should be used in a dose of 80-90 mg / kg / day, divided for 3 doses.
Optimum dosage form Augmentina for children from 6 to 12 years Tablets are 500 mg + 125 mg taken 2 times / day.
Patients with impaired renal function
Dose adjustment is based on the maximum recommended dose of amoxicillin and is based on the values of QC.
Adults
QC | Augmentin dosing regimen | |||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
> 30 ml / min | No dose adjustment required | |||||||||||||||||
10-30 ml / min | 1 tab. 500 mg + 125 mg 2 times / day or 1 tab. 250 mg + 125 mg (with mild to moderate infection) 2 times / day | |||||||||||||||||
30 ml / min. Children
|